Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atara Biotherapeutics (ATRA) Change in Inventory (2022 - 2025)

Atara Biotherapeutics filings provide 4 years of Change in Inventory readings, the most recent being -$10.7 million for Q1 2025.

  • On a quarterly basis, Change in Inventory fell 267.06% to -$10.7 million in Q1 2025 year-over-year; TTM through Dec 2025 was -$10.7 million, a 340.3% decrease, with the full-year FY2025 number at -$10.7 million, down 340.3% from a year prior.
  • Change in Inventory hit -$10.7 million in Q1 2025 for Atara Biotherapeutics, down from $160000.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $6.4 million in Q1 2024 to a low of -$10.7 million in Q1 2025.
  • Median Change in Inventory over the past 4 years was $2.1 million (2022), compared with a mean of $348500.0.
  • Biggest five-year swings in Change in Inventory: surged 96.41% in 2023 and later plummeted 275.51% in 2024.
  • Atara Biotherapeutics' Change in Inventory stood at $1.6 million in 2022, then surged by 96.41% to $3.1 million in 2023, then crashed by 94.86% to $160000.0 in 2024, then crashed by 6759.38% to -$10.7 million in 2025.
  • The last three reported values for Change in Inventory were -$10.7 million (Q1 2025), $160000.0 (Q4 2024), and -$4.8 million (Q3 2024) per Business Quant data.